Allyson Hart

Allyson Hart, MD, MS

Commitment to Patient-Centered Care

“I believe that 90% of patient care is listening. When I understand what you know about your illness and what your goals are, I can tailor my care and discuss treatment options that are right for you.”

Clinical Expertise

Dr. Hart is originally from Salt Lake City, Utah and received her Bachelors degree from the University of Utah. She attended medical school at the University of California San Francisco and spent additional time after medical school working at the San Francisco Department of Public Health, providing care for underserved populations. She also taught physiology at the medical school while completing her medical education fellowship. Dr. Hart returned to Utah for her internal medicine residency and practiced as an internist for two years at a teaching hospital prior to moving to Minneapolis. She completed her nephrology fellowship and Masters of Science in Clinical Research at the University of Minnesota. She continues to enjoy teaching medical students, residents and fellows and is an associate program director for the HCMC/VA Nephrology Fellowship Program. She loves caring for patients with kidney disease. Her research interests include kidney function in the elderly, management of chronic kidney disease and outcomes for patients on the kidney transplant waiting list.


  • Hart A, Patzer R. Equity in kidney transplantation: Policy change is only the first step. In Press: AJT. DOI: 10.1111/ajt.14743.
  • Schroff GR. Stoeker R, Hart A. Non-Vitamin K dependent oral anticoagulants for nonvalvular atrial fibrillation in patients with chronic kidney disease: Pragmatic considerations for the clinician. In press AJKD 2/2018.
  • Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Robinson A, Wainright JL, Haynes CR, Snyder JJ, Kasiske BL, Israni AK. OPTN/SRTR 2016 Annual Data Report: Kidney. American Journal of Transplantation 2018; 18(S1):18-113.
  • Hart A, Blackwell TL, Paudel ML, Taylor BC, Orwoll ES, Cawthon PM, Ensrud KE for the Osteoporotic Fractures in Men (MrOS) Study Group. Cystatin C and the Risk of Frailty and Mortality in Older Men. J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):965-970.
  • Hart A, Salkowski N, Snyder JJ, Israni AK, Kasiske BL. Beyond “Median Waiting Time”: Development and Validation of a Competing Risk Model to Predict Outcomes on the Kidney Transplant Waiting List. Transplantation 2016, 100(7) 1564-1570.

Medical School

  • University of California, San Francisco, CA, USA


  • Internal Medicine, University of Utah, Salt Lake City, UT, USA


  • Medical Education, University of California, San Francisco, CA, USA
  • Nephrology, University of Minnesota, Minneapolis, MN, USA


  • Board Certified in Internal Medicine and Nephrology